Clinical Trials
22
Active:5
Completed:6
Trial Phases
4 Phases
Phase 1:8
Phase 2:3
Phase 3:10
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (22 trials with phase data)• Click on a phase to view related trials
Phase 3
10 (45.5%)Phase 1
8 (36.4%)Phase 2
3 (13.6%)Not Applicable
1 (4.5%)A Phase I Clinical Study to Evaluate the Safety of PCV26 in Individuals ≥60
Phase 1
Not yet recruiting
- Conditions
- Pneumococcal Diseases
- Interventions
- First Posted Date
- 2025-05-14
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd
- Target Recruit Count
- 60
- Registration Number
- NCT06970756
- Locations
- 🇦🇺
Emeritus Research, Melbourne, Victoria, Australia
Clinical Trial of the S. Flexneri-S. Sonnei Bivalent Conjugate Vaccine
Phase 3
Not yet recruiting
- Conditions
- DysenteryDysentery, Shigella
- Interventions
- Biological: S. Flexneri-S. Sonnei bivalent conjugate vaccineBiological: Placebo
- First Posted Date
- 2025-02-20
- Last Posted Date
- 2025-02-20
- Lead Sponsor
- Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd
- Target Recruit Count
- 8000
- Registration Number
- NCT06838195
- Locations
- 🇧🇩
Icddr,B, Dhaka, Bangladesh
Clinical Study on the Combined Administration of 15-Valent Pneumococcal Conjugate Vaccine and Diphtheria, Tetanus, Pertussis Vaccine
Phase 3
Completed
- Conditions
- Streptococcus Pneumoniae Infections
- Interventions
- Biological: 15-Valent Pneumococcal Conjugate Vaccine and Diphtheria, Tetanus and Acellular pertussis (Component) Combined Vaccine (Adsorbed)Biological: Diphtheria, Tetanus and Acellular pertussis (Component) Combined Vaccine (Adsorbed)
- First Posted Date
- 2025-02-10
- Last Posted Date
- 2025-02-10
- Lead Sponsor
- Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd
- Target Recruit Count
- 1110
- Registration Number
- NCT06817187
- Locations
- 🇨🇳
Hebei Provincial Center for Disease Control and Prevention, Shijiazhuang, Hebei, China
Phase I/II Clinical Trial of 26-valent Pneumococcal Conjugate Vaccine
Phase 1
- Conditions
- Pneumococcal Vaccines
- Interventions
- First Posted Date
- 2024-11-25
- Last Posted Date
- 2025-01-27
- Lead Sponsor
- Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd
- Target Recruit Count
- 450
- Registration Number
- NCT06703203
- Locations
- 🇨🇳
Henan Provincial Center for Disease Control and Prevention, Shangqiu, Henan, China
Phase I Clinical Trial of Inactivated Rotavirus Vaccine in a Population Aged 6 Weeks-49 Years Old
Phase 1
Active, not recruiting
- Conditions
- Healthy Volunteers
- First Posted Date
- 2024-04-05
- Last Posted Date
- 2024-04-05
- Lead Sponsor
- Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd
- Target Recruit Count
- 375
- Registration Number
- NCT06350058
- Locations
- 🇨🇳
Hebei Provincial Center for Disease Control and Prevention, Shijiangzhuang, Hebei, China
- Prev
- 1
- 2
- 3
- 4
- 5
- Next
News
No news found